MYDA Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

MYDA Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,057	Closed	-$343K	–	156
2019 Q1	$343K	Buy	+2,057	New	+$252K	0.17%	88

Other funds holding ZSAN

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

MYDA Advisors's ZSAN Position: Q2 2019 in Review

MYDA Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q2 2019, closing a stake of 2,057 shares — an estimated $343K sold.

MYDA Advisors first reported a position in ZSAN in Q1 2019 and held it in 1 quarter. The position peaked at $343K in Q1 2019. 20 funds tracked by Wall St. Rank hold ZSAN as of Q2 2019.

MYDA Advisors reported no remaining Zosano Pharma Corporation position as of Q2 2019 after selling out during the quarter.
MYDA Advisors sold 2,057 Zosano Pharma Corporation shares in Q2 2019, an estimated $343K.
MYDA Advisors first reported a position in Zosano Pharma Corporation in Q1 2019 and held it in 1 quarter.
MYDA Advisors's Zosano Pharma Corporation position peaked at $343K in Q1 2019.
20 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2019.

Based on MYDA Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.